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Epidemiological research provides strong evidence for a link between repetitive work (RW) and the development of chronic
trapezius myalgia (TM). The aims were to further elucidate if an accumulation of sensitising substances or impaired oxygenation
is evident in painful muscles during RW. Females with TM (n = 14) were studied during rest, 30 minutes RW and 60 minutes
recovery. Microdialysate samples were obtained to determine changes in intramuscular microdialysate (IMMD) [glutamate],
[PGE2], [lactate], and [pyruvate] (i.e., [concentration]) relative to work. Muscle oxygenation (%StO2) was assessed using near-
infraredspectroscopy.Duringwork,allinvestigatedsubstances,exceptPGE2,increasedsigniﬁcantly:[glutamate](54%,P<. 0001),
[lactate] (26%, P<. 005), [pyruvate] (19%, P<. 0001), while the %StO2 decreased (P<. 05). During recovery [PGE2] decreased
(P<. 005), [lactate] remained increased (P<. 001), [pyruvate] increased progressively (P<. 0001), and %StO2 had returned to
baseline. Changes in substance concentrations and oxygenation in response to work indicate normal increase in metabolism but
no ongoing inﬂammation in subjects with TM.
1.Introduction
Epidemiological research provides strong evidence for a link
between repetitive work and the development of chronic
muscle pain [1–3], but to fully understand this relationship,
the pathophysiological mechanisms behind it needs further
elucidating. Several hypotheses that focus on hypoxia or
other metabolic eﬀects in the muscle have been suggested
[4–6].
While the muscle biopsy technique have only been able
to provide a “snap-shot” of the muscle chemistry [7, 8],
the possibilities for real-time in vivo investigations have
been greatly improved by combining microdialysis and near-
infrared spectroscopy [9, 10].
Microdialysis (MD) permits in vivo measurements of
c h a n g e si ns u b s t a n c ec o n c e n t r a t i o n si nd i ﬀerent tissues
in response to work, with minimal trauma [11]. MD is
performed by implanting a probe with a semipermeable
membrane in the tissue and slowly perfuses it with a
physiological solution. Sample collection is based on passive
diﬀusion of substances over the membrane, preferable
during steady-state conditions.
We have previously reported signiﬁcantly increased [lac-
tate] and [glutamate] and unchanged [prostaglandin E2,
PGE2]inthetrapeziusmuscleofhealthyfemales,inresponse
to low-load repetitive work (RW) which we interpreted as
normal responses to increased physical demands [9]. We
have also reported similar absolute [glutamate] and [PGE2]
in females with trapezius myalgia (TM) and asymptomatic
controls during rest [12]. Few other studies have used
MD to further elucidate the pathophysiology behind work-
related trapezius myalgia, and to some extent the ﬁndings2 Journal of Biomedicine and Biotechnology
are conﬂicting. In a laboratory study Rosendal et al. [13]
reported increased intramuscular [lactate] and [glutamate]
in response to RW in TM, but not in healthy controls,
ﬁndings which they were unable to verify in an occupational
ﬁeld study [14]. However, the pain subjects diﬀered in
severity of symptoms between studies. Ashina et al. [15]
reportedsimilar[glutamate]and[PGE2]intrapeziusmuscle
tender points in response to low-load static work in subjects
with chronic tension type headache (CTTH).
Near-infrared spectroscopy (NIRS) is a noninvasive
method for measuring muscle oxygenation (% StO2), that
is, the dynamic balance between oxygen delivery to and
consumption within a tissue [16, 17]. The technique is
basedontheprincipleofdiﬀerentialabsorptionpropertiesof
oxygenated and deoxygenated forms of haemoglobin (and to
a lesser extent, myoglobin) in the near infrared range (760–
850nm). NIRS is well suited to study the muscle microcircu-
lation due to the minimal absorption of light in small vessels
(i.e.,arterioles, capillaries, and venules) compared to in veins
and feed arteries [16, 17]. We have previously combined MD
and NIRS to study the eﬀects of RW of diﬀerent duration
[9] and RW with superimposed mental load [10]o n%S t O 2
in the pain-free trapezius muscle. We found small changes
in % StO2 and intramuscular lactate, indicative of a normal
response to increased physical demands [9]. In one recent
study no statistically signiﬁcant diﬀerences for oxygenated
haemoglobin during RW were reported between TM and
healthy controls [18].
The aims of this study, which was purposely designed
as a comparison to our previous study on asymptomatic
females [9], were to investigate whether an interstitial
accumulationofsensitisingsubstances(glutamate,PGE2),or
local metabolic changes indicative of an insuﬃcient oxygen
supply (e.g., greatly increased [lactate] and decreased %
StO2) is evident during RW in subjects with TM (n = 14).We
also wanted to investigate how % StO2, blood lactate, and
intramuscular [lactate] relate during RW in TM.
2.MaterialsandMethods
2.1. Participants. Fourteen females with trapezius myalgia
(TM) participated in the study. The group had a mean age
of 40 (±8) years, height 167 (±4)cm, weight 66 (±9.5)kg,
and BMI 23.0 (±2.3). The pain subjects were matched in
age to a group of healthy asymptomatic females, who had
participated in a previous study at our laboratory, and in
whichthesameexperimentalprotocolwasused[9],toadmit
c o m p a r i s o n st ob em a d e .
Participantswererequiredtoberight-handed,nonsmok-
ers, and not allergic to local anaesthesia. Further inclusion
criteria were as follows: during the clinical examination
subjects were required to (i) report pain of a duration of
at least 3 months from the neck-shoulder region, (ii) verify
pain in the upper part of the trapezius muscle with a pain
drawing, (iii) have the most pronounced complaints on the
side subjected to the greatest workload, and (iv) have reason
to believe that the pain was caused by their work, that is, that
they reported that the onset of their pain problems coincided
with performanceof static and/or repetitive work tasks. Also,
that they reported less pain when being oﬀ work, and/or
increased pain when coming back to work after a holiday.
All participants were examined by the same physiothera-
pist. Exclusion criteria were (a) previous trauma to the neck
orshoulder,(b)signsofshouldertendonitisorshoulderjoint
aﬀection, (c) signs of nerve aﬀection, (d) pronounced pain
from more than three body regions, and (e) neurological
or metabolic diseases, or (f) other diseases that demanded
continuous medication.
The Nordic Ministry Council Questionnaire (NMCQ)
[19] and the visual analogue scale (VAS) were used to
survey pain during the last 12 months and at the time of
participation. All participants reported pain from the neck-
shoulder area during the last 7 days. The median (range) for
the VAS-ratings of perceived pain in the right shoulder were
47 (12–79) for the last 12 months, 34 (14–63) for the last
7 days, and 27 (4–78) when arriving at the laboratory. The
mean (±SD) duration of complaints from the neck-shoulder
was 70.5 (±74.7) months. None of the subjects were on sick-
leave at the time of the study.
The participants were recruited through contacts with
local industries and through advertisement on the university
hospital’s intranet. The participants either worked at an
assembly line (in a car factory) or at a VDU-station, thus
performing work tasks of a repetitive and static character. All
participants gave their informed and signed consent prior to
inclusion in the study. The study conformed to the ethical
standards laid down in the 1964 Declaration of Helsinki
and was approved by the Ethical Committee of the Medical
Faculty of the University of Ume˚ a( Dnr 2004:M-150).
2.2. Methods
2.2.1. Experimental Protocol. The experimental design is
shown in Figure 1. The experimental conditions were exactly
the same as in the previous study on asymptomatic control
subjects [9] (same experimental protocol, same laboratory
roomandequipment,samecontrolledroomtemperature,all
probeinsertionswereperformedbythesamemedicaldoctor,
and all analyses were performed by the same laboratory
technicians). In addition to the previousprotocol, thepartic-
ipants perceived pain intensity were also assessed. All exper-
iments started at 7 a.m. The subjects were instructed not to
perform any kind of heavy physical exercise 48 hours prior
to the experiment, and to arrive fasting to the laboratory
where they were given a standardised breakfast. They were
also asked to refrain from using pain medication (NSAIDs)
three days before the experiment to avoid interference with
thepainsubstancesunderstudy,butalsoduetotheincreased
risk of bleeding during the procedure (paracetamol was
allowed). In the preparation period, before the MD-probe
was inserted and the optical probe for oxygen saturation
measurements was attached to the skin, measurements of
skin-fat layer (SFL) and trapezius muscle thickness over
the approximate site of the O2-probe were performed using
ultrasonography [9, 10]. Subjects then rested comfortably
seated for a total of 120 minutes (90 minutes stabilisation
+ 30 minutes baseline) before the 30 minutes work-period
began.Journal of Biomedicine and Biotechnology 3
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Figure 1: Experimental design. Schematic of the experimental design with 90 minutes stabilisation period, 30 minutes baseline, 30 minutes
work, and a 60 minutes recovery period. Arrows indicate time points for sampling of dialysate, assessment of perceived exertion with the
Borg CR-scale (RPE), assessment of perceived pain intensity with VAS (RPP), and capillary blood sampling (BS).
The repetitive low-load work, also used by Flodgren
et al. [9, 10], was designed to simulate an occupational
work task. It consisted in alternatively pushing in a piston
and pressing down a button with the use of a hand-
held manipulandum (130 grams), while seated at a table.
The subjects maintained a pace of 30 work cycles per
minute, with the aid of a metronome; a single piston push
followed by a button press constituting one work cycle.
The workstation was adjusted to each subject to provide
optimal ergonomic conditions (Figure 2). In a pilot study
(unpublished data) we used electromyography to assess the
trapezius muscle activity during the same type of work.
We then found the mean electrical activity to be 9.3% of
maximal voluntary contraction, which is similar to muscle
activity measured during low-load RW at a real work place
[20].
After the performance of the repetitive work subjects
rested, comfortably seated, for yet another 60 minutes (see
Figure 1). All subjects completed the work task. Throughout
the experiment local % StO2 was recorded, microdialysate
samples and capillary blood for lactate analyses were
obtained, subjectively perceived exertion (Borg CR-10) and
perceived pain intensity (VAS) were assessed, as shown in
Figure 1. The room temperature was between 22 and 24
degrees Celsius during experiments.
2.2.2. Microdialysis. After local anaesthesia of the skin and
subcutaneous tissue by injection of 1.5mL Xylocain
(10mgml−1), a microdialysis probe (CMA 60, CMA/Micro-
dialysis AB, Sweden, 20kDa molecular cut-oﬀ,m e m b r a n e
length 30mm, 0.5mm outer diameter) was implanted in
the middle third of the upper part of the trapezius muscle
in the direction lateral to medial. The same investigator
performed all probe insertions, and ultrasonography was
used to conﬁrm the placement of the probe (Aloka SSD-
2000,AlokaCo.,Ltd.,Japan).Thecatheterwassecuredtothe
skin with adhesives, connected to a portable syringe pump
(CMA 107, CMA/Microdialysis, AB, Sweden), and perfused
with solution containing 147mML−1Na+,4 m M L −1K+,
2.3mML−1Ca2+, and 156mML−1 Cl− (perfusion ﬂuid T1,
CMA/Microdialysis AB, Stockholm, Sweden), at a ﬂow rate
of 2μLmin −1. The pump was secured in level with the
probe.Afterinsertionoftheprobeinthemuscle,thesubjects
rested for 90 minutes to allow the tissue to stabilise after the
initial trauma of probe insertion [11, 12, 21]. Samples were
obtained every 30th minute during the initial two hours of
(a)
(b)
Figure 2: Repetitive work model. The low-load repetitive work
consisted of (a) pushing in a piston and (b) pressing down a button
on the table with a handheld manipulandum, at a pace of 30 work
cycles per minute.
rest, and every 15th minute during work and recovery. The
last sample obtained during rest will be referred to as base-
line. All probes kept functioning throughout the experiment.
The samples were immediately frozen to −70◦ until analyses
were performed. All samples were coded by the authors and
analysed blindly by an independent laboratory technician.
Lactate, glutamate and pyruvate were analysed with the
CMA600MicrodialysisAnalyser(CMAMicrodialysis,Solna,
Sweden), and PGE2 with a radioimmunoassay kit (NEN, Du
Pont, Boston, Mass, USA). The detection limits are 0.1mmol
× L−1 for lactate, 10μmol × L−1 for pyruvate and 1μmol ×
L−1 for glutamate. The detection limit for the PGE2 assay is
0.5pg mL−1.4 Journal of Biomedicine and Biotechnology
2.2.3.OxygenSaturation(%StO2). Measurementsoftrapez-
i u sm u s c l e%S t O 2 were performed during the experiment
using a near infrared spectrometer, NIRS (INSPECTRA
Tissue Spectrometer—model 325, Hutchinson Technology
Inc, Netherlands).
A self-adhesive O2-shield was placed on the skin over-
lying the upper part of the trapezius muscle, medial of
the MD-probe insertion site. Before connecting the optical
cable to the shield, the system was calibrated according to
instructions from the manufacturers, that is, inserted in
a light scattering calibrator for capturing reference light
intensities of all wavelengths. All tissue measurements were
related to the reference measurement, thereby converting
light intensity measurements to optical absorbance. Optical
absorbance values were further processed into a scaled
second derivative absorbance spectrum, whereby a measure
of percent oxygen saturation was obtained. The software
supplied with the In Spectra device allows for absolute values
of % StO2. The distance between the light transmitter and
the detector was 12mm, and the sampling frequency 0.3Hz.
2.2.4. Blood Sampling. In order to assess possible systemic
eﬀects in response to work, that is, changes in blood lactate
concentration, capillary blood samples were obtained from
a right hand ﬁnger at baseline, directly after work and after
the recovery period (Figure 1). The coded samples were
immediately put on ice, and were later the same day analysed
with a lactate analysis device YSI 2300 STAT plus (Clandon
Scientiﬁc, Famborough, UK) by an independent laboratory
technician.
2.2.5. Rating of Perceived Exertion (RPE) and Perceived Pain
Intensity (RPP). At baseline, and at the end of both the work
andtherecoveryperiod(seeFigure 1),subjectswererequired
to rate their (i) perceived exertion of the right shoulder in
accordance to the Borg CR-10 scale [22], with 0 = no fatigue
and10 = severefatigue,and(ii) their perceivedpain intensity
in the right shoulder, using the nonhatched VAS, marked
at one end as “no pain at all” and at the other “worst pain
imaginable” [23].
2.2.6. Estimation of Skin-Fat Layer and Trapezius Muscle
Thickness. Measurements of skin-fat layer (SFL) and trapez-
ius muscle thickness were performed using ultrasonography,
with a 75mm probe (Aloka SSD-2000, Aloka Co., Ltd.,
Japan). Measurements were performed at three measuring-
points over the upper trapezius muscle medially of the MD-
probe insertion point. (1, 3.75 and 7.5cm)
2.2.7. Data Analyses and Statistics. SPSS statistical software,
version 13.0 (Chicago, III, USA) was used for all analyses.
The level of signiﬁcance was set to P<. 05. The Kolmogorov-
Smirnov test was used to test for normal distribution, and
data for all variables was normally distributed.
The change in substance concentration relative to work
was calculated as the baseline values subtracted from the
values obtained after work (work-baseline = change).
Pearson test was used to investigate possible correlations
between (i) pain substances (glutamate and PGE2) and pain
intensity, (ii) IMMD lactate and local muscle oxygenation,
(iii) local (IMMD lactate) and systemic (blood lactate)
changes, and (iv) key metabolites (IMMD lactate and
glutamate).
Repeated measures ANOVA (RM ANOVA) were used
for the within group comparisons of data for the diﬀerent
variables in response to work and recovery (except for the
RPE- and RPP-data). If the assumption of sphericity of
variance was violated in the RM ANOVA, the Huyn-Feldt
correction was used. The sequential Bonferroni [24]w a s
used to compare speciﬁc pairs of means when the RM
ANOVA revealed a signiﬁcant diﬀerence.
To relate the oxygenation and the MD-data in time, a
mean value of the oxygenation data recorded during a 5-min
period just before each sampling of dialysate was calculated.
Data are presented as means ± SD in both text and graphs,
except for the RPE and RPP which are presented as median
and range. Wilcoxon nonparametric test was used for the
within group comparisons of the subjective ratings.
3. Results
3.1. Biochemical Alterations during Work. During work [glu-
tamate] increased (54%) (P<. 0001, F = 16.957), and
decreased to 26% below baseline during the recovery period
(P<. 0001, F = 14.293) (see Figure 3(a)).
The mean IMMD [PGE2] remained unchanged during
work (P = .300), but showed a signiﬁcant overall decrease
(40% lower than baseline) during recovery (P = .004,
F = 5.224) (see Figure 3(b)).
An overall signiﬁcant increase (28%) in mean IMMD
[ l a c t a t e ]w a sf o u n di nr e s p o n s et ow o r k( P = .003,
F = 10.813), and recovery (P>. 001, F = 7.392) as compared
to baseline (see Figure 3(c)).
Also, [pyruvate] increased signiﬁcantly during work (P<
.0001, F = 36.4), and continued to increase progressively (up
to 60% > baseline) during the recovery period (P<. 0001, F
= 25.3) (see Figure 3(d)).
3.2. Oxygen Saturation (% StO2). A small, but signiﬁcant,
decrease in % StO2 in response to work was found (P = .016,
F = 7.816), and directly after the cessation of work baseline
was re-established (see Figure 4).
3.3.Blood Lactate. Plasma[lactate]decreasedsigniﬁcantlyin
response to work (P = .005; F = 8.109), from 1.1mmol ×
L−1 (SD ± 0.3) at baseline to 0.9mmol × L−1 (SD ± 0.2)
after work and baseline was re-established at the end of the
recovery period (1.3 ± 0.6).
3.4. Rating of Perceived Exertion (RPE) and Pain Intensity
(RPP). The median (range) RPE in the right shoulder (Borg
CR-10), increased signiﬁcantly from 1.5 (0–3.5) at baseline
to 7.0 (3.0–7.0) after work, and remained increased also
after recovery 2.25 (0–4.5) The median (range) RPP in the
right shoulder (VAS) increased (P<. 001) from 17.5 (2–
52) at baseline, to 69 (28–82) after work and tended to be
signiﬁcantly increased also at the end of recovery 26.5 (3–69)
(P = .054).Journal of Biomedicine and Biotechnology 5
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Figure 3: (a) IMMD glutamate concentrations. Mean (±SD) intramuscular microdialysate [glutamate] (μML −1) at baseline, in response
to work and recovery. Percent diﬀerence in comparison to baseline is depicted on the right hand y-axis. Signiﬁcant diﬀerences with respect
to baseline concentrations are indicated with ∗ for a P-value <. 05 and ∗∗ for a P-value <. 001. (b) IMMD PGE2 concentrations. Mean
(±SD) intramuscular microdialysate [PGE2]( μgmL −1) at baseline, in response to work and recovery. Percent diﬀerence in comparison to
baseline is depicted on the right hand y-axis. Signiﬁcant diﬀerences with respect to baseline concentrations are indicated with ∗ for a P-
value <.05 and ∗∗ for a P-value <. 001. (c) IMMD lactate concentrations. Mean (±SD) intramuscular microdialysate [lactate] (mML−1)
at baseline, in response to work and recovery. Percent diﬀerence in comparison to baseline is depicted on the right hand y-axis. Signiﬁcant
diﬀerences with respect to baseline concentrations are indicated with ∗ for a P-value <. 05 and ∗∗ for a P-value <. 001. (d) IMMD pyruvate
concentrations. Mean (±SD) interstitial microdialysate [pyruvate] (mML−1) at baseline, during work and recovery. Percent diﬀerence in
comparison to baseline is depicted on the right hand y-axis. Signiﬁcant diﬀerences with respect to baseline concentrations are indicated with
∗ for a P-value <. 05 and ∗∗ for a P-value <. 001.
3.5. Skin-Fat Layer and Trapezius Muscle Thickness. The
mean SFL (fascia included) and the mean trapezius mus-
cle thickness for the three measuring-points medial to
the MD-probe insertion point (1, 3.5 and 7cm) were
4.6 ± 0.5, 4.7 ± 0.3 and 4.5 ± 0.3mm and 12.3 ± 0.4mm,
and12.2 ± 0.5and10.0 ± 0.6mm,respectively.Meanvalues
for the SFL (4.6 ± 0.4mm) and the trapezius muscle
thickness (11.5 ± 0.5mm) were calculated.
3.6. Correlations. A signiﬁcant negative correlation was
found between changes in IMMD [lactate] and plasma
[lactate] during work (P<. 05), and a tendency to a
correlation between IMMD lactate and % StO2 (P = .073).
T h ep a i ni n t e n s i t yw a su n c o r r e l a t e dt oI M M D[ g l u t a m a t e ]
(P = .276) and [PGE2]. (P = .492), but signiﬁcantly
correlated to the perceived exertion in the shoulder (P<
.0001). A signiﬁcant correlation was also found between6 Journal of Biomedicine and Biotechnology
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Figure 4: Muscle oxygen saturation. Mean (±SD) local trapezius
muscle oxygen saturation (% StO2) at baseline, during work and
recovery. Signiﬁcant diﬀerences with respect to baseline concentra-
tions are indicated with ∗ for a P-value <.05.
changes in IMMD [glutamate] and IMMD [lactate] during
work (P<. 05).
4. Discussion
The main results of the present study were: signiﬁcantly
increased IMMD [glutamate] and [lactate], unchanged
[PGE2], and decreased % StO2 i nt h et r a p e z i u sm u s c l ed u r -
ing work in females with TM. Furthermore, that glutamate
and PGE2 were uncorrelated to pain intensity.
4.1. Glutamate and PGE2. Glutamate is a well-known pain-
mediator in the CNS [25, 26], and suggested to contribute
to localised pain and peripheral sensitisation in certain pain
conditions [13, 27, 28]. It is also a key metabolite in cellular
metabolism[29].Inourstudywefoundasigniﬁcantincrease
in IMMD [glutamate] in response to work (54%), which
was in accordance with our previous results for healthy
controls [9]. However, at all time points [glutamate] was
lower in TM, and uncorrelated to pain intensity [9]. While
we found a moderate increase in [glutamate], the suggested
concentration needed to excite and sensitize nociceptors
is 2-3-fold greater than physiological concentrations [30].
Theseﬁndingstakentogetherdonotsupportaninvolvement
of glutamate in peripheral pain conditions. They are best
interpreted as signs of normally increased metabolism in
response to work.
The increase in [glutamate] in TM in response to work
was also in accordance with results reported by others [13].
In contrast, Rosendal et al. found overall higher [glutamate]
in TM, and a correlation between pain ratings and [gluta-
mate] [13]. A recent study reported higher [glutamate] in
TM, but no deﬁnite baseline was used as comparison [14]. It
should be noted that the increased [glutamate] reported [13,
14] was similar to absolute resting concentrations reported
in the trapezius of pain subjects and controls [12].
PGE2 is known to act directly on nociceptors, and for its
abilitytosensitisenociceptorstoothersubstances[31].PGE2
is also an important regulator of blood ﬂow [16, 32], but its
eﬀect is highly dependent on intensity and mode of exercise,
that is, during high intensity dynamic contractions, [PGE2]
isreportedtoincreasesigniﬁcantly,buttoremainunchanged
during low intensity static contractions [33].
In our study IMMD [PGE2] did not increase in response
to work, which is in agreement with our previous results on
healthy subjects [9]. Furthermore, [PGE2] was uncorrelated
to pain intensity. These ﬁndings suggest that there is no
ongoing inﬂammation in the chronic phase of TM. Our
ﬁndings and conclusions are in general agreement with the
results for [PGE2]r e p o r t e db yA s h i n ae ta l .[ 15].
However, tissue damage and inﬂammation may still be
initiating factors for the development of muscle pain [34],
and a shift from pain mechanisms in the periphery to the
CNS may occur at a later stage in the disease process [35].
4.2. Lactate, Pyruvate, and % StO2. Lactate is an important
fuel source and a glukoneogenetic precursor [36, 37].
Muscles produce lactate to yield energy during anaerobic
conditions, but there is also a signiﬁcant lactate production
inthefullyoxygenatedcontractingmuscle[38].Inourstudy,
wefoundsigniﬁcantlyincreased[lactate]inresponsetowork
TM, which was in accordance with our previous results for
healthy females [9]. Ashina et al. [39] also found similar
[lactate] in pain subjects and controls in response to static
work. However, higher [lactate] in TM in response to RW
has been reported [13, 18], ﬁndings which the same authors
wereunabletoverifyinanoccupationalstudy[14].However,
many of the subjects in [13] were on sick-leave, while in the
latter participants were occupationally active [18].
Duringprolongedlow-intensityworkoxidationoflactate
into pyruvate is enhanced, and muscles revert from net
lactate release to net uptake [40]. We found a signiﬁcant
increase in [pyruvate] during work, and a progressive
increase during recovery, which diﬀered from our results
on healthy controls [9]. Larsson et al., reported unchanged
[pyruvate]duringworkinbothmyalgicandhealthyworkers,
but this study had no real baseline for comparison [14]. It
may be speculated that the higher [pyruvate] may be due to
a greater activation of fatigable type II ﬁbres in subjects with
TM, in comparison to asymptomatic subjects, which would
beinaccordancewithmuscleactivationpatternsreportedfor
chronic pain cases [41].
As far as we know, we are ﬁrst to combine MD and NIRS
to investigate biochemical alterations in the trapezius muscle
in response to RW [9, 10]. In the present study, we found a
signiﬁcant decrease in local muscle % StO2 during work, and
a tendency to a signiﬁcant correlation between % StO2 and
IMMD [lactate]. Our ﬁndings are in general agreement with
the results reported by Sjøgaard et al. [18] .T h ed e c r e a s ei n
%S t O 2 and the increase in IMMD [lactate] did not diﬀer
from our previous results on healthy controls, that is why
these ﬁndings must be interpreted as a normal response to
increased metabolic demands.
Blood[lactate]decreasedduringworkandwasnegatively
correlated with IMMD [lactate], which may be explained byJournal of Biomedicine and Biotechnology 7
an enhanced uptake and use of lactate as a fuel by active
muscles during prolonged low-load work [40]. During high-
intensity work, [lactate] in muscle and blood is correlated
[42, 43],while low-intensity work is suggested not to cause
systemic eﬀects [16, 44].
4.3. Methodological Considerations
4.3.1. Microdialysis. After the trauma of probe insertion,
interstitial substance concentrations are abnormal and the
inﬂux of substances random. To avoid biased results suﬃ-
cient time for the establishment of a new steady-state must
be allowed [11]. We applied a 90 minutes stabilisation time,
whichisampletimeforstabilisationoflactate,pyruvate[21],
glutamate [12], but maybe not for PGE2, which decreased
below baseline during recovery.
Refraining fromcalibrating the probe in vivo is suggested
to introduce bias since the relative recovery of substances
(RR) is reported to increase with high intensity exercise in
the absence of true interstitial changes [11, 44]. However,
most studies of low-load work have reported no change
[13, 14, 39, 45] or a small change [13]i nR Ro fl a c t a t ei n
the trapezius muscle during work. This lack of change in RR
may be explained by that intramuscular pressure does not
increase in the trapezius during low-load work [46], and that
the changes in blood ﬂow are small [39],which are suggested
not to aﬀe c tR Ro fs u b s t a n c e si nv i v o[ 47, 48]. We did not
assess RR, and cannot therefore exclude the presence of a
bias, although we ﬁnd it unlikely that this bias is signiﬁcant.
4.3.2. Near-Infrared Spectroscopy (NIRS). Ideally, we also
should have measured blood-ﬂow (BF), since metabolic
insuﬃcienciesmaybetheresultofimpairedBF[49].Existing
results are conﬂicting and provide no convincing evidence
for impaired BF in TM as compared to healthy controls
[14, 18, 39, 45].
NIRS may provide information about a possible mis-
match between metabolic requirements and blood ﬂow
locally in muscle [16] and is considered a valid [50], and
reliable tool [51] for measuring local muscle oxygenation
during work.
Heterogeneity of blood ﬂow and oxygen consumption
distributionswithinamuscle[43,52,53],workintensityand
leveloftraining[16]andmodeofexercise[54]mayinﬂuence
NIRS-measurements. In this, and in previous studies [9, 10],
the work and the position of the probe were standardised, to
enable appropriate comparison between studies [55].
The probe was chosen to ensure that data was obtained
from the trapezius, and not from underlying muscle. It
may be argued that the measuring depth of the probe may
not have been suﬃcient to accurately assess changes in
%StO2. However, the muscle volume measured with NIRS
is controversial, and while the signal is presumed to be
obtained mostly from a tissue depth of approximately 60%
of the transmitter-detector distance, a banana-shaped region
of sensitivity extends both above and below this depth [17].
Since the skin overlying muscle in lean subjects contributes
<5% of the signal [16], our measurement should mainly
originate from muscle.
The discrepancies between the few studies that have
studiedtheeﬀectoflow-loadworkonmetabolismandsensi-
tisingsubstances,bothinmethodology,andsubjectsstudied,
emphasise that more independent studies are needed.
5. Conclusions
The changes in substance concentrations and oxygenation
found in this study indicate normal increase in metabolism
inresponsetoworkbutnoongoinginﬂammationinsubjects
with TM. Our results do not support the role of glutamate as
a pain mediator in the periphery.
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